PhaseBio Pharmaceuticals Inc
PHASDelisted Dec 21, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001169245
PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding PhaseBio Pharmaceuticals Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 50 | 39 | −11 |
| Shares | 23.4M | 22.2M | −1.25M (−5.4%) |
| Value | $14.1M | $3.90M | −$10.2M (−72.3%) |
New holders (1)
Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Simplex Trading, LLC | 3,317 | $0 | 0.00% |
Sold out (12)
Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| CHI Advisors LLC | 750,000 | $450.0K |
| New Legacy Group, LLC | 240,575 | $144.0K |
| Marshall Wace, LLP | 123,039 | $73.0K |
| Citadel Advisors LLC | 107,953 | $65.0K |
| Prudential Financial Inc | 44,100 | $26.0K |
| Virtu Financial LLC | 31,852 | $19.0K |
| Millennium Management LLC | 13,501 | $8.00K |
| Two Sigma Securities, LLC | 12,845 | $8.00K |
| Two Sigma Advisers, LP | 12,700 | $8.00K |
| UBS Group AG | 9,830 | $6.00K |
| Toronto Dominion Bank | 4,670 | $3.00K |
| Curi Capital | 823 | $0 |